Healthleap Closes $38M Funding Round to Expand AI-Powered Hospital Risk Detection
The South African startup has secured $38 million across seed and Series A rounds to scale its platform that uses language models to identify hospitalized patients at risk of undiagnosed conditions like malnutrition and delirium.
Healthleap, which has built an AI system that analyzes patient records to surface individuals at heightened risk of overlooked medical conditions, announced it has raised $38 million in combined seed and Series A funding. An $8 million seed round was co-led by Sequoia Capital and First Round Capital, while Hummingbird Ventures led the $30 million Series A. The company has chosen not to reveal its valuation.
The startup was established in South Africa in 2022 by siblings Jemima and Josiah Meyer. Healthleap began by offering a clinical nutrition tool that Jemima had developed for dietitians, but later shifted direction to create a broader platform. This platform targets hospital inpatients who may have conditions such as malnutrition or delirium that frequently escape early detection, according to CEO and co-founder Josiah Meyer.
A patient's chart holds two kinds of data. Labs, weights, and vital signs sit in structured fields, but the most telling signs sit in clinicians' written notes: poor appetite, recent weight loss, muscle loss, trouble swallowing. Our developing approach is extracting affirmative or negated mentions of these clinical concepts in an easily extensible and scalable way.
Josiah Meyer, CEO and co-founder of Healthleap
Healthleap's system is currently operating across more than 50 hospital locations, where it screens for conditions including malnutrition and delirium. The company has also developed screening programs for aspiration pneumonia, pressure ulcers, and readmission risk in congestive heart failure patients, all of which are undergoing additional clinical validation.
The platform integrates with hospital electronic health record systems and leverages language models to extract clinical information from provider notes—such as mentions of weight changes or swallowing difficulties. This extracted data feeds into risk assessment models alongside structured data points like lab values and vital signs, enabling the system to flag patients who warrant further clinical attention. Healthleap emphasizes that its software does not make diagnoses but rather identifies cases requiring additional review.
Each night, we analyze every adult inpatient's record: lab results, vital signs, weights, medications, diet orders, diagnoses, clinicians' notes, and more. Each morning, we write a risk score into the care team's existing workflow with a dashboard accessible that holds additional information about the patients' trends.
Josiah Meyer
Malnutrition emerged as a logical entry point for the company's focus. The condition frequently remains undetected in hospital settings despite its significant impact on patient outcomes. Studies indicate that 20 to 50 percent of hospitalized adults experience malnutrition, which has been associated with extended hospital stays, slower wound healing, increased infection rates, and elevated mortality.
Over the past year, Healthleap expanded from three hospital partners to more than 50, with customers now including Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist, and Emory Healthcare. The company reported revenue growth exceeding 10 times during this period, though specific figures were not disclosed.
The company offers three-year contracts with pricing tied to a hospital's licensed bed count and incorporates an outcome-based pricing structure. According to Meyer, the pricing model is anchored to measurable financial returns that hospital finance teams validate and attribute to Healthleap's platform. He stated that contractually, the company ensures customers receive returns equal to multiples of the contract price, with every current customer achieving at least a 5x return on investment, and some exceeding 20x annual total ROI.
At the Hospital of the University of Pennsylvania, Healthleap's malnutrition identification program generated $23.8 million in annualized financial impact, comprising $6.3 million from additional reimbursement and $17.5 million from reduced hospital stays.
The company intends to allocate the new capital toward engineering, product development, sales, and customer success functions as it expands its condition-detection capabilities. Meyer indicated that Healthleap aims to eventually support screening for more than 40 major health conditions and extend its reach into outpatient and home care settings.